Govt. to Settle Rs. 23.87 Bn Outstanding Pharmaceutical Dues 💊

The Cabinet has approved the settlement of long-standing arrears for pharmaceutical supplies to stabilize the national healthcare supply chain. • Overall Settlement: The Government will pay Rs. 23.87 Bn in installments throughout 2026. This covers verified dues for the period from January 2018 to December 2023. • Beneficiaries: Payments are owed to the State Pharmaceutical Corporation (SPC), State Pharmaceutical Manufacturing Corporation, and various local manufacturers for drugs purchased and distributed via the Medical Supplies Division. • Verification Process: While the SPC reported total arrears of Rs. 32.92 Bn (dating back to 2008), a study by the Department of State Enterprises confirmed Rs. 23.87 Bn as the immediate payable amount for the 2018–2023 window. • Future Commitments: Outstanding dues for the period between 2008 and 2017 are currently being calculated, suggesting further financial outlays may be required once assessments are finalized. 📈 This move aims to provide liquidity to the pharmaceutical sector and ensure the uninterrupted supply of essential medicines within the public health system.